partments. We found a significant impairment in class I-dependent GVHD mediated by gzm B -/-CD8' CTL, whereas class Il-dependent GVHD was not altered using gzm B -/-CD4' effectors. In a hybrid resistance model, gzm B -/- In vitro analysis of immune effector cells from mice bearing a null mutation in the gzm B locus has shown profound functional defects. In standard lytic assays, gzm B-deficient CD8' CTL and lymphokine-activated killer (LAK) cells exhibit a severe defect in their ability to rapidly induce apoptosis in allogeneic target cells, but late cytotoxicity recovers
In contrast, gzm B-deficient NK cells cannot induce apoptosis in target cells despite high effector:target ratios or prolonged incubation times. ' The Chbdiak-Higashi Syndrome, an inherited disorder of humans resulting in increased susceptibility to infections, provides independent confirmation of the critical importance of the granule exocytosis pathway for CTL-and NK-mediated cytotoxicity. CTL, NK cells, and neutrophils from these patients share a common defect in granulopoiesis. The primary and secondary granules fuse aberrantly; consequently, the lytic contents cannot be delivered to a target cell.' AIthough Chkdiak-Higashi CTL still exhibit some cytotoxicity, Chbdiak-Higashi NK cells are virtually devoid of cytotoxicity.' Mice homozygous for the beige mutation have a similar phenotype." These observations support the conclusion drawn from the analysis of perforin and gzm B-deficient mice that the granule exocytosis pathway is important for CTL cytotoxicity and essential for NK cytotoxicity.
Murine transplant models developed in the 1980s dissected the roles of CD4' and CD8' CTL in the pathogenesis of GVHD.I"l3 Congenic strains of C57BW6 mice expressing either a mutant class I (B6.C-H-2b'"l) or class I1 (B6.C-H2b""2) allele served as hosts for these experiments. These mice were reconstituted after lethal irradiation with syngeneic marrow combined with purified T-cell subsets from the partially mismatched parental strain (BL/6, H-2b). After alloattack by T cells on the marrow graft, the hosts succumbed as a result of marrow aplasia at day 10 to 14 (in the case of a class I mismatch) or day 20 to 24 (class 11 mismatch) post-BMT. These results indicated that single antigen H-2 mismatches that provoke either class I-or class 11-restricted responses can lead to 100% mortality from acute GVHD when as few as IO5 donor-derived T cells are infused.
The cellular basis of the host-versus-graft (ie, rejection) response has not been as well characterized. The prototypical 
MATERIALS AND METHODS
Mice. gzm B-deficient mice were derived in a C57BL/6 X 129/ Sv background, as previously described! Heterozygote crosses yielded littermates genotypically -I-or +I+ at the gzm B locus, determined by Southern blot analysis of tail DNA.' B6.C-H-2b"", B6.C-H-2bm'Z, Balbk, CBA/J, and 129/SvJ mice were obtained from the Jackson Laboratory (Bar Harbor, ME).
Acute GVHD model. Lymphocytes were isolated from the mesenteric lymph nodes of 8-to 12-week-old gzm B +I+ or -I-sexmatched littermate donors by passage through a stainless steel mesh. T-cell subsets were then prepared, as previously described." In brief, antibody-mediated complement lysis was performed by adsorbing antibodies to B cells (monoclonal antibody [MoAb] J1 Id) and CD4' cells (MoAb RL.172) or CD8' cells (MoAb 3.155) at 4°C for 30 minutes at a concentration of lo7 IymphocyteslmL in RPM1 1640 (Sigma, St Louis, MO) supplemented with 5% (vol/vol) heat-inactivated fetal calf serum, 1 mmol/L sodium pyruvate, 15 mmol/L HEPES, 2 mmol/L I-glutamine, nonessential amino acids at 0.1 moll L each, 25 U/mL penicillin, 25 pg/mL streptomycin, and 75 pmoV L /3-mercaptoethanol. The lymphocytes were then incubated at 37°C for 1 hour in the presence of complement (rabbit Low-Tox-M; Cedarlane Laboratories, Hornby, Ontario, Canada). T cells were recovered by centrifugation through a 1.1 19 g/mL Histopaque gradient (Sigma), washed twice in complete media before counting (>95% viable by Trypan blue exclusion), and combined at a dose of 1.0 X lo6 cells with the marrow graft before infusion. Unpooled T cells derived from single donors were used in all transplants, except for the fully allogeneic experiments.
Bone marrow grafts were prepared from the hosts by flushing both femora with 1 mL of 1 X Hebs (20 mmol/L HEPES, pH 7.05, 137 mmol/L NaCI, 5 mmol/L KCI, 0.7 mmol/L Na,HPO,; 6 mmoV L dextrose) through a 22-G needle. After settling debris, cells were washed once in phosphate-buffered saline (PBS) and counted. A dose of 2 X IO6 viable nucleated marrow cells was combined with the T-cell graft in a volume of 450 pL of PBS and infused via a lateral tail vein.
Hosts were conditioned with gamma irradiation from a "'CS source at a rate of 95.2 cGylmin 24 hours before transplantation. Balb/c hosts received 700 cGy, whereas the bml x 129 and bm12 X 129 hybrids received 1, OOO cGy. Animals were housed in a pathogen-free barrier facility in a manner approved by the Animal Investigation Committee at Washington University. Mice were observed daily and killed if moribund or unable to take food. H-2 immunophenotyping. One hundred microliters of whole blood was obtained from the retro-orbital sinus of an anesthetized animal. After 10 minutes of incubation at 4°C in red blood cell (RBC) lysis buffer (150 mmol/L NH,Cl, 10 mmol/L KHCO,, 0.1 mmol/L Na2EDTA, pH 7.1-7.4), the nucleated cells were washed twice in PBS and resuspended in serum-free media. Cells (IO') were stained with fluorescein isothiocyanate (FITC) antimouse H-2Kb and phycoerythrin (PE) antimouse H-2K' (Pharmingen, San Diego, CA) and analyzed on a FACScan (Becton Dickinson Immunocytometry Systems, San Jose, CA).
Statistics. Survival after BMT in the GVHD model was analyzed by the Kaplan-Meier method. 26 The groups were compared using Log-Rank analysis. The Mann-Whitney test was used to compare engraftment among the experimental groups in the hybrid resistance model. from acute GVHD (Fig 1) when the lymphocytes were derived from gzm B -/-donors compared with gzm B +/+ donors (36% v 12% at 40 days; P = .00657). gzm B +/+ and +/-T cell donors were indistinguishable in this analysis and were used interchangeably in these and subsequent experiments. Complete blood counts at day 10 post-BMT documented severe pancytopenia only in those animals that subsequently died of acute GVHD (data not shown). Similar results were obtained in the fully allogeneic model (Fig 2) . Significantly fewer Balb/c hosts survived when gzm B +/+, CDCdepleted, CD8+ T-cell donors were used compared with gzm B -/-donors (40% v 6% at 40 days; P < .00622). These transplants into hosts mismatched at all H-2 and non-H-2 loci confirm that the data obtained in the bml system are accounted for by the single class I mismatch and are not an artifact of minor histocompatibility loci introduced by the BL6 X 129 strain differences.
RESULTS

Acute
Of note, mortality in the gzm B +/+ cohort did not reach loo%, as seen by Sprent et al. '3 This may be due to strain differences in our model or to a reduced susceptibility to death from infection in contemporary barrier facilities.
Acute GVHD model: CD4+ CTL. A single antigen class
I1 mismatch acute GVHD model was created using (bm12 X 129) F1 mice as hosts. In this case, gzm B +/+ or -/-, CD8-depleted, CD4' T cells from littermate donors were infused into sex-matched littermate bm12 X 129 hosts, which were histocompatible at all major and minor loci except for the single mutant class I1 (H-2bm12) allele. In contrast to the class I model, there was no difference in survival of the bm12 X 129 hosts when gzm B +/+ or -/-CD4+ CTL were infused (Fig 3) . A lower T-cell dose would be unlikely to bring out a phenotypic difference between the two experimental groups, because mortality in the wild-type group is reduced when fewer than lo6 cells are used.13 These findings support the hypothesis that the perforin-granzyme pathway is not essential for CD4+ CTL-mediated cytotoxicity in vivo. Hybrid resistance model. Hosts for the hybrid resistance model were created by crossing CBA/J (H-2k) and gzm B -/-(H-2b) mice. The F1 progeny were then backcrossed to the gzm B -/-parent. F2 hybrids bearing both haplotypes (H-2b") and either gzm B genotype (+/-or -I-) were the experimental hosts. Engraftment was measured after the infusion of wild-type BL6 X 129 (H-2') marrow into a lethally irradiated host. The missing self hypothesis predicts that a radioresistant cell within the F2 hybrid hosts will recognize and kill the parental marrow stem cells because those cells do not express the H-2k haplotype. Homozygotes (H-2b) within the F2 litters provided concurrent positive controls because they provide no barrier to engraftment of the parental BW6 X 129 marrow. Mock-transplanted animals (PBS only) were used as negative controls.
All syngeneic control animals engrafted, with splenic Iz5IUdR incorporation (mean, 2.2%) in good agreement with previously published report^.'^ As expected, gzm B +/-H2b/k hosts rejected bone marrow grafts from the H-2' parental strain, as reflected by very low splenic Iz5IUdR uptake (mean, 0.19%; Fig 4) . Surprisingly, gzm B -/-H-2m hosts also rejected the mismatched marrow completely (mean ' %JdR uptake, 0.08%). Pretreatment of the gzm B +/-or 4-hosts with antimouse TNFa (n = 9), yIFN (n = 2), or the combination of both antibodies (n = 2) did not significantly change the outcome, because persistent complete rejection of haplo-identical marrow was observed (data not shown).
DISCUSSION
The models used in the present study provide tools for the in vivo dissection of the role of gzm B in each of the lymphocyte compartments. To summarize the findings, we note a moderate, but significant reduction in acute GVHD mediated by gzm B 4-CD8+ CTL as compared with wildtype CD8+ CTL. In contrast, CD4+ CTL-mediated cytotoxicity and hybrid resistance were not affected by the loss of gzm B activity in these models.
The molecular basis of cellular cytotoxicity is being elucidated using complementary experimental systems. Evidence accumulated thus far implicates two major pathways used by CTL. The importance of the Ca'+-dependent granule exocytosis pathway has been shown by the targeted disruption of the key effector molecules, perforin and gzm B. CTL and LAK cells from perforin-or gzm B-deficient mice have a severe defect in their ability to rapidly induce apoptosis in susceptible target ~e l l s .~, '~ NK cells from these mice are completely unable to induce apoptosis in susceptible target cell^.^.'^ The second mechanism of cellular cytotoxicity involves the Ca'+-independent interaction of Fas, a ubiquitously ex- Although CTL may also kill target cells through secretion of soluble mediators such as TNFa, experiments with mice genetically deficient in both perforin and Fas suggest that these two pathways account for nearly all T-cell cytotoxicity in standard in vitro lytic assay^.^^.^ CD8+ CTL in the experiments described here were able to kill mismatched bone marrow cells and cause aplastic death in over half of the animals analyzed, despite the lack of gzm B. This implies that, just as the in vitro assays have shown, gzm B-independent apoptotic mechanisms are operative in CD8+ CTL. It further follows from the in vitro experiments that the Fas-Fas ligand interaction probably accounts for much of this residual cytotoxicity in gzm B-deficient mice. CTL deficient in both gzm B and Fas ligand have a killing defect intermediate between gzm B-deficient and perforin/Fas ligand-deficient CTL (S. Shresta and T.J. Ley, unpublished observations). Because perforin is required for delivery of gzm A and B to the target cell cytoplasm, but is unable to induce apoptosis itself,35 gzm A may account for the difference between the gzm B/Fas ligand-deficient and the perforin/Fas ligand-deficient CTL in these assays. Therefore, we would predict that the gzm B-independent cytotoxicity in this GVHD model is mediated primarily by the Fas pathway with a smaller contribution from gzm A.
Our finding that gzm B is important, but not essential for CD8+ CTL-mediated attack on allogeneic hematopoietic grafts is consistent with the recent report that perforin-deficient mice have impaired, but not fully disabled resistance to cardiac allograft^.^^ In addition, Selvaggi et a137 have shown that bone marrow grafts from perforin-deficient mice will survive and engraft in fully incompatible hosts with no mortality from GVHD unless the T-cell inoculum is increased substantially. Although this model differs from ours, it further supports the conclusion that the perforin/granzyme pathway is critical for in vivo cytotoxicity in the CD8+ compartment, but that important redundancy (eg, Fas) remains.
CD4+ CTL-mediated cytotoxicity, in contrast, appears to be completely gzm B-independent in the class 11-restricted GVHD model. This is consistent with the in vitro data that suggets that Fas is the sole mediator in this compartment. This possibility is being formally tested using Fas liganddefective CTL in similar transplant experiments.
It is harder to reconcile the failure of gzm B deficiency to impact on hybrid resistance with the strong in vitro phenotype of gzm B -/-NK cells. One possible explanation is that the pool of NK cells is heterogenous, ie, armed with different effector molecules. Similarly, individual NK cells may have redundant pathways (eg. Fas or other granzymes) that are used in vivo, but escape detection in an in vitro assay using homogenous targets such as YAC-1 cells. However, Fas is unlikely to account for gzm B-independent NK cytotoxicity, because Fas ligand-deficient NK cells have normal activity in lytic assays against NK susceptible target For personal use only. on October 31, 2017. by guest www.bloodjournal.org From cells (S. Shresta and T.J. Ley, unpublished observations). Furthermore, allogeneic resistance was recently shown to be unaffected by null mutations of perforin and Fas.3x This experiment provides strong independent confirmation of our observation that mutations that fully disarm NK cells have no effect on hybrid resistance. Finally, the secretion o f the cytotoxic cytokines TNFa or yIFN do not seen to account for the gzm B-independent hybrid resistance we have observed, although the in vivo administration of antibodies does not conclusively rule out the possibility that some biologically active cytokine may remain. In summary, it appears that hybrid resistance remains intact when NK cells are fully disarmed.
Alternatively, the paradigm that NK cells mediate hybrid resistance may be incorrect. Complementary experiments from Aguila and Weissmad8" support this conclusion. These investigators found that a sorted population of NK1.1+ cells from an H-2 hybrid or allogeneic background were unable to lyse hematopoietic stem cells in vitro.38a Furthermore, transgenic animals overexpressing a "gzm A-driven'' diphtheria toxin gene39 had no alteration in hybrid resistance, although these animals contain little, if any, NK activity.3xa This provides strong evidence that NK cells are not essential for hybrid resistance. In this case, another radioresistant immune effector cell (such as the macrophage) may account for hybrid and/or allogeneic resistance. Although it is clear from our work and the work of Aguila et al that hybrid resistance is not altered when NK cells are disarmed or deleted, it remains a formal possibility that NK cells are the primary mediators of hybrid resistance in the intact animal and that an alternative effector cell with allogeneic restriction is able to fully compensate in the absence of an active NK compartment.
Genetic models such as these may ultimately lead to a complete understanding of the molecular basis of immune cell effector function. Hopefully, this will provide new therapeutic strategies for the clinical problems of GVHD and graft rejection.
